SG11201601681QA - Metabolically optimized cell culture - Google Patents
Metabolically optimized cell cultureInfo
- Publication number
- SG11201601681QA SG11201601681QA SG11201601681QA SG11201601681QA SG11201601681QA SG 11201601681Q A SG11201601681Q A SG 11201601681QA SG 11201601681Q A SG11201601681Q A SG 11201601681QA SG 11201601681Q A SG11201601681Q A SG 11201601681QA SG 11201601681Q A SG11201601681Q A SG 11201601681QA
- Authority
- SG
- Singapore
- Prior art keywords
- cell culture
- optimized cell
- metabolically optimized
- metabolically
- culture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2511/00—Cells for large scale production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Reproductive Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361889815P | 2013-10-11 | 2013-10-11 | |
| PCT/US2014/059993 WO2015054554A1 (fr) | 2013-10-11 | 2014-10-10 | Culture cellulaire à métabolisme optimisé |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201601681QA true SG11201601681QA (en) | 2016-04-28 |
Family
ID=52813657
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201601681QA SG11201601681QA (en) | 2013-10-11 | 2014-10-10 | Metabolically optimized cell culture |
| SG10201800772TA SG10201800772TA (en) | 2013-10-11 | 2014-10-10 | Metabolically optimized cell culture |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201800772TA SG10201800772TA (en) | 2013-10-11 | 2014-10-10 | Metabolically optimized cell culture |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20160244725A1 (fr) |
| EP (3) | EP3812453A1 (fr) |
| JP (3) | JP6663854B2 (fr) |
| KR (4) | KR102358807B1 (fr) |
| CN (2) | CN105637085A (fr) |
| AU (2) | AU2014331776B2 (fr) |
| CA (1) | CA2926049C (fr) |
| DK (2) | DK3351620T3 (fr) |
| EA (2) | EA033783B1 (fr) |
| ES (2) | ES2678945T3 (fr) |
| HK (2) | HK1223122A1 (fr) |
| HU (2) | HUE039551T2 (fr) |
| IL (2) | IL244511A0 (fr) |
| MX (2) | MX2020011334A (fr) |
| PL (2) | PL3351620T3 (fr) |
| SG (2) | SG11201601681QA (fr) |
| WO (1) | WO2015054554A1 (fr) |
| ZA (1) | ZA201601550B (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105637085A (zh) | 2013-10-11 | 2016-06-01 | 瑞泽恩制药公司 | 代谢优化的细胞培养物 |
| US20160244726A1 (en) * | 2013-10-11 | 2016-08-25 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
| US11390663B2 (en) | 2013-10-11 | 2022-07-19 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
| JP7260011B2 (ja) * | 2017-03-31 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260020B2 (ja) * | 2017-03-31 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260018B2 (ja) * | 2017-03-31 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260021B2 (ja) * | 2017-04-27 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260009B2 (ja) * | 2017-04-27 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7310947B2 (ja) * | 2017-04-27 | 2023-07-19 | 株式会社三洋物産 | 遊技機 |
| JP7260012B2 (ja) * | 2017-04-27 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7260013B2 (ja) * | 2017-04-27 | 2023-04-18 | 株式会社三洋物産 | 遊技機 |
| JP7310945B2 (ja) * | 2017-04-27 | 2023-07-19 | 株式会社三洋物産 | 遊技機 |
| JP7272480B2 (ja) * | 2017-04-27 | 2023-05-12 | 株式会社三洋物産 | 遊技機 |
| JP7310952B2 (ja) * | 2017-04-27 | 2023-07-19 | 株式会社三洋物産 | 遊技機 |
| CN111344558A (zh) | 2017-10-06 | 2020-06-26 | 龙沙有限公司 | 使用拉曼光谱法自动控制细胞培养 |
| WO2019079188A1 (fr) | 2017-10-16 | 2019-04-25 | Regeneron Pharmaceuticals, Inc. | Bioréacteur à perfusion et procédés d'utilisation associés |
| JP7471220B2 (ja) * | 2017-11-30 | 2024-04-19 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | 哺乳動物細胞の培養方法 |
| GB201810772D0 (en) * | 2018-06-29 | 2018-08-15 | Ge Healthcare Bio Sciences Ab | Method in bioprocess purification system |
| JP2020151559A (ja) * | 2020-06-24 | 2020-09-24 | 株式会社三洋物産 | 遊技機 |
| JP2020151560A (ja) * | 2020-06-24 | 2020-09-24 | 株式会社三洋物産 | 遊技機 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| KR970029803A (ko) | 1995-11-03 | 1997-06-26 | 김광호 | 반도체 메모리장치의 프리차지 회로 |
| US6165741A (en) | 1997-05-30 | 2000-12-26 | The Trustees Of The University Of Pennsylvania | Method for rapid detection of bacterial growth in cultures |
| US5972650A (en) | 1997-06-26 | 1999-10-26 | Brigham And Women's Hospital | Tetracycline repressor regulated mammalian cell transcription and viral replication switch |
| EP1392859B1 (fr) | 2001-01-16 | 2006-05-10 | Regeneron Pharmaceuticals, Inc. | Isolement de cellules exprimant des proteines secretees |
| US6953692B2 (en) * | 2001-12-18 | 2005-10-11 | Bayer Pharmaceuticals Corporation | Device and method for seed-train expansion of mammalian cells |
| CA2417689C (fr) | 2002-03-05 | 2006-05-09 | F. Hoffmann-La Roche Ag | Methodes ameliorees de culture in vitro de cellules de mammiferes |
| US7039770B1 (en) | 2002-03-05 | 2006-05-02 | Juniper Networks, Inc. | Low latency request dispatcher |
| US8673589B2 (en) | 2002-05-29 | 2014-03-18 | Regeneron Pharmaceuticals, Inc. | Inducible eukaryotic expression system |
| ATE472597T2 (de) | 2003-05-15 | 2010-07-15 | Wyeth Llc | Kontrollierte glukosezufuhr für tierzellkultur |
| US7531327B2 (en) * | 2004-07-23 | 2009-05-12 | Immunomedics, Inc. | Methods and compositions for increasing longevity and protein yield from a cell culture |
| US7300773B2 (en) * | 2004-08-27 | 2007-11-27 | Wyeth Research Ireland Limited | Production of TNFR-Ig |
| TWI374935B (en) | 2004-08-27 | 2012-10-21 | Pfizer Ireland Pharmaceuticals | Production of α-abeta |
| EP1943333A2 (fr) * | 2005-11-02 | 2008-07-16 | Wyeth a Corporation of the State of Delaware | Procedes pour adapter des cellules de mammifere |
| EP1973576B1 (fr) | 2005-11-28 | 2019-05-15 | Genmab A/S | Anticorps monovalents recombines et leurs procedes de production |
| US7575890B2 (en) | 2006-01-18 | 2009-08-18 | Oxygen Enterprises, Ltd. | Method for rapid detection and evaluation of cultured cell growth |
| US8192951B2 (en) | 2006-11-03 | 2012-06-05 | Wyeth Llc | Glycolysis-inhibiting substances in cell culture |
| ES2522615T3 (es) | 2007-06-04 | 2014-11-17 | Regeneron Pharmaceuticals, Inc. | Regiones de expresión y estabilidad potenciadas |
| EP3327132A3 (fr) | 2007-08-09 | 2018-07-18 | Wyeth LLC | Utilisation de la perfusion pour améliorer la production d'une culture cellulaire en mode semi-continu dans des bioréacteurs |
| EP2331678B1 (fr) * | 2008-06-13 | 2015-09-30 | Janssen Biotech, Inc. | Procédés destinés à l'obtention d'une haute densité de cellules viables dans des cultures de cellules de mammifères |
| US8470552B2 (en) * | 2009-10-12 | 2013-06-25 | Keck Graduate Institute | Strategy to reduce lactic acid production and control PH in animal cell culture |
| RU2644651C2 (ru) * | 2010-04-26 | 2018-02-13 | Новартис Аг | Среда для культивирования клеток |
| JP6050226B2 (ja) * | 2010-05-28 | 2016-12-21 | ジェネンテック， インコーポレイテッド | Ｌｄｈ及びｐｄｈｋ発現を下方制御することによる乳酸レベルの低下及びポリペプチド生産の増加 |
| TWI637057B (zh) | 2012-11-09 | 2018-10-01 | 拜爾沙納有限公司 | 具交替生物反應器用途之不連續進料批次製程 |
| CN105637085A (zh) | 2013-10-11 | 2016-06-01 | 瑞泽恩制药公司 | 代谢优化的细胞培养物 |
-
2014
- 2014-10-10 CN CN201480055499.4A patent/CN105637085A/zh active Pending
- 2014-10-10 EA EA201690600A patent/EA033783B1/ru active IP Right Revival
- 2014-10-10 MX MX2020011334A patent/MX2020011334A/es unknown
- 2014-10-10 KR KR1020217011547A patent/KR102358807B1/ko active IP Right Grant
- 2014-10-10 KR KR1020227003381A patent/KR102510238B1/ko active IP Right Grant
- 2014-10-10 EP EP20193898.2A patent/EP3812453A1/fr active Pending
- 2014-10-10 KR KR1020167009163A patent/KR102243980B1/ko active IP Right Grant
- 2014-10-10 WO PCT/US2014/059993 patent/WO2015054554A1/fr active Application Filing
- 2014-10-10 KR KR1020237008467A patent/KR102610425B1/ko active IP Right Grant
- 2014-10-10 EA EA201991976A patent/EA201991976A1/ru unknown
- 2014-10-10 ES ES14851841.8T patent/ES2678945T3/es active Active
- 2014-10-10 EP EP18161278.9A patent/EP3351620B1/fr not_active Revoked
- 2014-10-10 HU HUE14851841A patent/HUE039551T2/hu unknown
- 2014-10-10 SG SG11201601681QA patent/SG11201601681QA/en unknown
- 2014-10-10 AU AU2014331776A patent/AU2014331776B2/en active Active
- 2014-10-10 JP JP2016547976A patent/JP6663854B2/ja active Active
- 2014-10-10 DK DK18161278.9T patent/DK3351620T3/da active
- 2014-10-10 EP EP14851841.8A patent/EP3055409B1/fr active Active
- 2014-10-10 PL PL18161278T patent/PL3351620T3/pl unknown
- 2014-10-10 CN CN202210497778.2A patent/CN114717196A/zh active Pending
- 2014-10-10 MX MX2016004564A patent/MX2016004564A/es active IP Right Grant
- 2014-10-10 HU HUE18161278A patent/HUE051049T2/hu unknown
- 2014-10-10 CA CA2926049A patent/CA2926049C/fr active Active
- 2014-10-10 US US15/028,521 patent/US20160244725A1/en not_active Abandoned
- 2014-10-10 DK DK14851841.8T patent/DK3055409T3/en active
- 2014-10-10 SG SG10201800772TA patent/SG10201800772TA/en unknown
- 2014-10-10 ES ES18161278T patent/ES2833471T3/es active Active
- 2014-10-10 PL PL14851841T patent/PL3055409T3/pl unknown
-
2016
- 2016-03-04 ZA ZA2016/01550A patent/ZA201601550B/en unknown
- 2016-03-08 IL IL244511A patent/IL244511A0/en unknown
- 2016-09-23 HK HK16111206.9A patent/HK1223122A1/zh unknown
-
2018
- 2018-10-02 HK HK18112564.1A patent/HK1253275A1/zh unknown
- 2018-11-06 IL IL262833A patent/IL262833A/en unknown
-
2020
- 2020-02-17 JP JP2020024484A patent/JP6967620B2/ja active Active
- 2020-08-04 US US16/984,531 patent/US20210087535A1/en active Pending
-
2021
- 2021-01-14 AU AU2021200193A patent/AU2021200193B2/en active Active
- 2021-10-25 JP JP2021173755A patent/JP7377243B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262833A (en) | Metabolically enriched cell culture | |
| HK1223553A1 (zh) | 細胞 | |
| SG11201509558VA (en) | Back-contact-type solar cell | |
| HK1221250A1 (zh) | 用於培養細胞的結構件 | |
| EP2879794A4 (fr) | Culture cellulaire | |
| IL245392A0 (en) | A method for cell culture | |
| EP2988346A4 (fr) | Boîtier de cellule | |
| EP2975110A4 (fr) | Dispositif de culture cellulaire | |
| GB201318262D0 (en) | Sram Cells | |
| GB201420277D0 (en) | Cell culture system | |
| GB201312332D0 (en) | Cell locations | |
| GB201310031D0 (en) | Cell | |
| PL2978839T3 (pl) | Sposób hodowli komórek | |
| GB201211873D0 (en) | Cell culture | |
| GB201308905D0 (en) | Cell culture | |
| GB201306488D0 (en) | Cell culture | |
| EP3067936A4 (fr) | Cellule solaire | |
| EP3067940A4 (fr) | Cellule solaire | |
| GB201320573D0 (en) | T Cell | |
| GB201317589D0 (en) | Cell | |
| GB201303132D0 (en) | Cell Line | |
| GB201213450D0 (en) | Cell culture devices |